35-subject trial evaluating safety, performance of Surmodics’ Sundance™ Sirolimus Drug-Coated BalloonEDEN PRAIRIE, Minn. (BUSINESS WIRE) #Acquisition Surmodics, Inc. (NASDAQ:SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, announced today that Professor.
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.